Last updated: Oct 2, 2026, 12:00 AM

Galmed Pharmaceuticals Ltd Exchange (NASDAQ, USD)

GLMD

3.55
-0.08 (-2.20%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
153.57%
3 year return (CAGR)
-22.27%
5 year return (CAGR)
-62.99%
10 year return (CAGR)
-40.71%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
3.70M
Price/Sales
-
Ent value
4.18M
Price/Book
0.27
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-60.33%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open3.60
Daily high3.63
Daily low3.50
Daily Volume6K
All-time high3232.80
1y analyst estimate12.00
Beta0.68
EPS (TTM)-2.04
Dividend per share0.00
Ex-div date-
Next earnings date1 Apr 2026

Ready to capitalize on Galmed Pharmaceuticals Ltd's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
GLMDS&P500
Current price drop from All-time high-99.89%-1.76%
Highest price drop-99.99%-56.47%
Date of highest drop8 Jun 20269 Mar 2009
Avg drop from high-74.98%-10.65%
Avg time to new high526 days12 days
Max time to new high2085 days1805 days
News
No items found